Retinal Physician – “Real-World” Outcomes of Anti-VEGF Therapy in Neovascular AMD in the United States
[ad_1]
In our “real world” study of 49,485 “wet” AMD patient-eyes treated with anti-VEGF agents, visual acuity improved by only 1 letter at 1 year! Outcomes fall far short of randomized clinical trial results. New therapies are needed.
Differences between real-world and clinical trial outcomes continue to confuse researchers and clinicians.
[ad_2]
Return to main website.